[Economic aspects of prevention]
- PMID: 18210026
- DOI: 10.1007/s00108-007-1994-7
[Economic aspects of prevention]
Abstract
This paper deals with health economic aspects of prevention. After giving a definition of the term prevention, published estimates of the burden of disease attributable to selected risk factors are presented. These estimates suggest that a considerable share of morbidity, mortality and health care costs may be avoided through prevention. Subsequently, the paper describes the methods that can be used to analyze the cost-effectiveness of preventive services. Typical problems arise from the necessity to estimate long-term costs and effects, which often requires modeling. A specific problem refers to whether so-called unrelated future health care costs caused by other diseases in life years gained through prevention should be included when calculating the costs of prevention. Economic evaluations of preventive services published in the literature often report very favorable cost-effectiveness ratios. In order to increase the efficiency of health care, more cost-effective preventive services should be developed and used.
Similar articles
-
[Economic aspects of prevention and treatment of overweight and obesity in children and adolescents].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011 May;54(5):611-20. doi: 10.1007/s00103-011-1262-9. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011. PMID: 21547654 German.
-
[Economic aspects of prevention: an international perspective].Gesundheitswesen. 2009 Oct;71(10):610-6. doi: 10.1055/s-0029-1239569. Epub 2009 Nov 2. Gesundheitswesen. 2009. PMID: 19885761 Review. German.
-
Economic analysis of preventive medicine in Japan--based on two empirical studies.Jpn Hosp. 1997 Jul;16:55-62. Jpn Hosp. 1997. PMID: 10174051 No abstract available.
-
Cost of depression in Europe.J Ment Health Policy Econ. 2006 Jun;9(2):87-98. J Ment Health Policy Econ. 2006. PMID: 17007486
-
Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions?Pharmacoeconomics. 2008;26(10):815-30. doi: 10.2165/00019053-200826100-00003. Pharmacoeconomics. 2008. PMID: 18793030 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources